Shares of Apollo hospitals made headlines in business on Wednesday, 12 February and traded 3% further Dividend Record date this week.
Stock of Nifty 50 Hospital on Monday, with its quarterly earnings, announced an interim dividend 9 per share.
“Board of Directors said that an interim dividend (180% marks price price for the financial year ended on 31 March 2025 for the financial year ended on 31 March 2025 (180% marks price (180% marks 180%of).
On 15 February, the company set forward as a record date for the purpose of paying the said interim dividend. This means, dividends will be paid to equity shareholders, whose names appear in the register of members of the company/beneficial owners on 15 February.
According to the filing, Apollo Hospital will pay the said interim dividend on or before February 28.
Apollo Hospital Stock Price Trend
The shares of Apollo hospitals on Wednesday slid 6 months after their slide. Stock increased by 2.86% 6,496.10 per share on BSE today.
With today’s rise, Apollo Hospitals share price has scored its four -day defeat.
Apollo Hospital Q3 Show
For Q3 FY25, Apollo Hospitals reported 14% year-on (YOY) increase in revenue 5,527 crores. After Tax, its consolidated profit increased to 52% yoy 372 crore compared to 245 crores in Q3 FY24. EBITDA integrated for quarter increased 24% yoy 762 crores.
By December 31, 2024, Apollo hospitals operated 7,996 beds in their network (except AhLL and managed beds). According to the company’s Q3 income report, compared to 66% in the same period last year, the overall occupation rate was 68%, while the company’s Q3 was inspired by a significant increase in the patient’s flow.
Brokerage Motilal Oswal Financial Services (MOSL) stated that Apollo Hospitals Enterprises (APHS) gave an in-line performance for 3QFY25. “APHS saw a widespread growth in hospitals, health (online/offline pharmacy), and health and lifestyle (AHLL) segment. The company reported healthy development in the number of patients and patients per patients and patients.” .
Although Brokerage reduced the estimate of 4%/5% earnings for FY26/FY27, an increase in operational expenses related to factoring and commissioning of new hospitals in moderation in GMV for Apollo 24/7. It also modified to reduce its target price 7,800 maintaining a ‘buy’ rating.
Disclaimer: The above views and recommendations belong to individual analysts or broking companies, not mint. We recommend investors to investigate with certified experts before taking any investment decisions.
